5Kim M H,Decena,Bruckman D,et al.Use patterns of low-molecular weight heparin and the impact on length of stay in patients hospitalized for atrial fibrillation[J].American Heart Journal,2003,145 (4):665-669.
3Furberg CD,Psaty BM,Manolio TA,et al.Prevalance of artiial fibrillation in elderly subjects[J].Am J Cardiol,1994,74(3):236-241.
4Stroke prevention in atrial fibrillation investigators.Adjusted-dose warfarin versus low-intensity,fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation:Stroke prevention in atrial fibrillation Ⅲ randomized clinic trial[J].Lancet,1996,348:633-638.
6Levine MN,Raskob G,Landefeld S,et al.He morrhagic complications of anticoagulant treatment[J].Chest,2001,119(1Suppl):108S-121S.
7[2]Vemmos K N, Takis CE, Georgilis K , et al. the Athens Stroke registry:results of a five-year hospital-based study,Cerebrovasc Dis, 2000, 10∶133-141.
8[4]Yamanouchi H, Cerebral embolism in elderly patients with atrial fibrillation.Nippon Ronen Igakkai Zasshi,1993,30(5)∶348.
9[1]Alcade TP, Ribera CJM, Cerebrovascular accidents and atrial fibrillatton in the elderly patient . An Med Interna, 1995,12 (8): 369.
10Blann AD, Lip GY, Beevers DG, et al. Soluble P-selectin in atherosclerosis: a comparison with endothelial cell and platelet markers.Thromb Haemost,1997;77(6):1077.
